国内精品综合久久久40P_国产成人a人亚洲精品无码_亚洲人成色77777在线观看大战_伊人精品成人久久综合97_手机在线亚洲国产精品_五月婷婷六月丁香动漫_亚洲综合另类小说色区大陆_天天爱天天做久久狼狼_欧美日本免费视频观看_消息称老熟妇乱视频一区二区

News
Now: Home > About Us > News
CGTN shot the production plants of Puracap and reported innovation pathway of Optics Valley Biolake represented by Humanwell Healthcare
DATE:2017-02-23 VIEWS:2697

Wuhan's Biotech Zone has been emphasizing the concept of innovation since its inception. Perhaps this is why it has attracted more than 1200 biotech companies. Humanwell Puracap here is one of them. Its drugs have been approved by US Food and Drug Administration. They were sold worldwide. That's something achieved it couldn't have been imagined just a few years ago.

WANG XUEHAI, CEO

HUMANWELL HEALTHCARE GROUP

Here's in the zone the local authorities tries to speed up the drug approvals. So it takes less time for us to get the products into the market. I think it is also a kind of innovation.

THE JOURNALIST IN PURACAP

China's still in the early stage of developing its pharmaceutical manufacturing industry but it'll be still a main focus for the country over the next ten years as known as the way to drive Made-in-China 2025 Strategy.